These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36445611)

  • 1. Effects of the New Thrombolytic Compound LT3001 on Acute Brain Tissue Damage After Focal Embolic Stroke in Rats.
    Jiang Y; Ji Y; Zhou IY; Liu N; Sun PZ; Ning M; Dumont AS; Wang X
    Transl Stroke Res; 2024 Feb; 15(1):30-40. PubMed ID: 36445611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early insulin glycemic control combined with tPA thrombolysis reduces acute brain tissue damages in a focal embolic stroke model of diabetic rats.
    Fan X; Ning M; Lo EH; Wang X
    Stroke; 2013 Jan; 44(1):255-9. PubMed ID: 23117722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. tPA Mobilizes Immune Cells That Exacerbate Hemorrhagic Transformation in Stroke.
    Shi K; Zou M; Jia DM; Shi S; Yang X; Liu Q; Dong JF; Sheth KN; Wang X; Shi FD
    Circ Res; 2021 Jan; 128(1):62-75. PubMed ID: 33070717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
    Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
    Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of PI3Kγ by AS605240 plus low-dose tissue plasminogen activator (tPA) combination improves thrombolytic therapy in a rat model of embolic stroke.
    Jin R; Zhong W; Liu S; Wang M; Li G
    Neurosci Lett; 2020 Nov; 738():135339. PubMed ID: 32882317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose tPA plus annexin A2 combination attenuates tPA delayed treatment-associated hemorrhage and improves recovery in rat embolic focal stroke.
    Jiang Y; Fan X; Yu Z; Cheng C; Wang XS; Lo EH; Sun X; Wang X
    Neurosci Lett; 2015 Aug; 602():73-8. PubMed ID: 26149229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
    Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
    Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THR-18, a 18-mer peptide derived from PAI-1, is neuroprotective and improves thrombolysis by tPA in rat stroke models.
    Krakovsky M; Polianski V; Nimrod A; Higazi A; Leker RR; Lamensdorf I
    Neurol Res; 2011 Nov; 33(9):983-90. PubMed ID: 22081002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke.
    Hassanipour M; Zarisfi M; Ehsani V; Allahtavakoli M
    Life Sci; 2020 Sep; 256():117450. PubMed ID: 32087233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
    Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
    Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination treatment with N-acetyl-seryl-aspartyl-lysyl-proline and tissue plasminogen activator provides potent neuroprotection in rats after stroke.
    Zhang L; Chopp M; Teng H; Ding G; Jiang Q; Yang XP; Rhaleb NE; Zhang ZG
    Stroke; 2014 Apr; 45(4):1108-14. PubMed ID: 24549864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats.
    Fan X; Lo EH; Wang X
    Stroke; 2013 Mar; 44(3):745-52. PubMed ID: 23422086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin extends the therapeutic window for tPA to 6 h after the onset of embolic stroke in rats.
    Zhang L; Chopp M; Jia L; Cui Y; Lu M; Zhang ZG
    J Cereb Blood Flow Metab; 2009 Nov; 29(11):1816-24. PubMed ID: 19638998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
    Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P
    Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Analysis of Different Methods of Ischemia/Reperfusion in Hyperglycemic Stroke Outcomes: Interaction with tPA.
    Hafez S; Hoda MN; Guo X; Johnson MH; Fagan SC; Ergul A
    Transl Stroke Res; 2015 Jun; 6(3):171-80. PubMed ID: 25683354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke.
    Zhu H; Fan X; Yu Z; Liu J; Murata Y; Lu J; Zhao S; Hajjar KA; Lo EH; Wang X
    J Cereb Blood Flow Metab; 2010 Jun; 30(6):1137-46. PubMed ID: 20068577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opening the window: Ischemic postconditioning reduces the hyperemic response of delayed tissue plasminogen activator and extends its therapeutic time window in an embolic stroke model.
    Esmaeeli-Nadimi A; Kennedy D; Allahtavakoli M
    Eur J Pharmacol; 2015 Oct; 764():55-62. PubMed ID: 26123846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postischemic intracarotid treatment with TNK-tPA reduces infarct volume and improves neurological deficits in embolic stroke in the unanesthetized rat.
    Zhang RL; Zhang L; Jiang Q; Zhang ZG; Goussev A; Chopp M
    Brain Res; 2000 Sep; 878(1-2):64-71. PubMed ID: 10996136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.
    Sumii T; Lo EH
    Stroke; 2002 Mar; 33(3):831-6. PubMed ID: 11872911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI evaluation of BBB disruption after adjuvant AcSDKP treatment of stroke with tPA in rat.
    Ding G; Zhang Z; Chopp M; Li L; Zhang L; Li Q; Wei M; Jiang Q
    Neuroscience; 2014 Jun; 271():1-8. PubMed ID: 24769225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.